In summary, these results demonstrate that OLFML1 directly interacts with IGF2BP3 in CRC cells, with the Olfactomedin-like domain of OLFML1 binding to the RRM domains of IGF2BP3. This evidence concerns the gene IGF2BP3 and colorectal carcinoma.